BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Malham M, Carlsen K, Riis L, Paerregaard A, Vind I, Fenger M, Wewer V. Plasma calprotectin is superior to serum calprotectin as a biomarker of intestinal inflammation in ulcerative Colitis. Scand J Gastroenterol 2019;54:1214-9. [PMID: 31526273 DOI: 10.1080/00365521.2019.1665097] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Martos L, Oto J, Fernández-Pardo Á, Plana E, Solmoirago MJ, Cana F, Hervás D, Bonanad S, Ferrando F, España F, Navarro S, Medina P. Increase of Neutrophil Activation Markers in Venous Thrombosis-Contribution of Circulating Activated Protein C. Int J Mol Sci 2020;21:E5651. [PMID: 32781781 DOI: 10.3390/ijms21165651] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Cherubini F, Cristiano A, Valentini A, Bernardini S, Nuccetelli M. Correction to: Circulating calprotectin as a supporting inflammatory marker in discriminating SARS-CoV-2 infection: an observational study. Inflamm Res 2021. [PMID: 34792617 DOI: 10.1007/s00011-021-01512-8] [Reference Citation Analysis]
3 Ge C, Lu Y, Shen H, Zhu L. Monitoring of intestinal inflammation and prediction of recurrence in ulcerative colitis. Scand J Gastroenterol 2022;:1-12. [PMID: 34994661 DOI: 10.1080/00365521.2021.2022193] [Reference Citation Analysis]
4 Macias-Muñoz L, Frade-Sosa B, Iniciarte-Mundo J, Hidalgo S, Morla RM, Gallegos Y, Sanmarti R, Auge JM. Analytical and clinical evaluation of DiaSorin Liaison® Calprotectin fecal assay adapted for serum samples. J Clin Lab Anal 2022;:e24258. [PMID: 35122317 DOI: 10.1002/jcla.24258] [Reference Citation Analysis]
5 Gao J, Ulvik A, McCann A, Ueland PM, Meyer K. Microheterogeneity and preanalytical stability of protein biomarkers of inflammation and renal function. Talanta 2021;223:121774. [PMID: 33303176 DOI: 10.1016/j.talanta.2020.121774] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Nevejan L, Strypens T, Van Nieuwenhove M, Boel A, Cattoir L, Meeus P, Bossuyt X, De Neve N, Van Hoovels L. Prognostic value of circulating calprotectin levels on the clinical course of COVID-19 differs between serum, heparin, EDTA and citrate sample types. Clin Chim Acta 2021;525:54-61. [PMID: 34919937 DOI: 10.1016/j.cca.2021.12.011] [Reference Citation Analysis]
7 Mylemans M, Nevejan L, Van Den Bremt S, Stubbe M, Cruyssen BV, Moulakakis C, Berthold H, Konrad C, Bossuyt X, Van Hoovels L. Circulating calprotectin as biomarker in neutrophil-related inflammation: Pre-analytical recommendations and reference values according to sample type. Clin Chim Acta 2021;517:149-55. [PMID: 33689693 DOI: 10.1016/j.cca.2021.02.022] [Reference Citation Analysis]